VERZENIO

eli lilly canada inc🇨🇦 Health Canada

Approval Id: 6c846ac6fd8be4b5
Drug Approval Canada Name: VERZENIO
Product Name: VERZENIO
Status: Marketed
Status Date: 2019-07-03
Original Market Date: 2019-07-03
Din: 02487136
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EF03 ABEMACICLIB
Atc Name: l 01 ef 03
Aig Number: 0161330004
Company Name: eli lilly canada inc
Company Address: SUITE 900, Exchange Tower, 130 King Street West, Toronto, Ontario, Canada, M5X 1B1

ABEMACICLIB

200 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

6c846ac6fd8be4b5

Type

Standard